Financial insights of CLCS

MyFinsight

For the quarter ending 2025-03-31.

Income Statement	2025-03-31	2024-12-31
Research and development-Nonrelated Party	500,683	460,020.25*
Research and development-Related Party	14,500	14,500*
General and administrative	483,404	485,540.75*
Total operating expenses	998,587	960,061
Loss from operations	-998,587	-960,061*
Interest expense-Nonrelated Party	216,923	31,619*
Interest expense-Related Party	210,314	162,977.5*
Interest expense - amortization of debt discount-Nonrelated Party	6,686	39,055.25*
Interest expense - amortization of debt discount-Related Party	79,951	38,423.25*
Change in fair value of derivative and warrant liabilities-Nonrelated Party	23,068	88,293.5*
Change in fair value of derivative and warrant liabilities-Related Party	7,542	11,208.75*
Gain on extinguishment of note payable	-	4,473.25*
Total other expense	-483,264	-168,099.5*
Net loss	-1,481,851	-1,128,160.5*
Dividend attributable to series a, b, and c preferred stockholders	352,248	343,797*
Net loss applicable to common stockholders	-1,834,099	-1,471,957.5

Basic EPS	-0.04	-0.035
Diluted EPS	-0.04	-0.035
Basic Average Shares	45,038,244	41,870,597
Diluted Average Shares	45,038,244	41,870,597

Unit: Dollar. Numbers labeled with * are estimated quarterly values.